Clinical Colorectal Cancer

Clinical Colorectal Cancer

临床大肠癌

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Clinical Colorectal Cancer》是由Elsevier出版社于2001年创办的英文国际期刊(ISSN: 1533-0028,E-ISSN: 1938-0674),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为医学-肿瘤学。作为SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比0.2062...%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比77.36%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在53篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Clinical Colorectal Cancer审稿周期约为 12周,或约稿 。该刊近年未被列入国际预警名单,年发文量约53篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 53 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 118 / 322

63.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 151 / 322

53.26%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:5.5 SJR:1.336 SNIP:0.842
学科类别 分区 排名 百分位
大类:Medicine 小类:Gastroenterology Q2 47 / 167

72%

大类:Medicine 小类:Oncology Q2 146 / 404

63%

期刊发文

  • Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis

    Author: Yaqi Li, Yang Feng, Weixing Dai, Qingguo Li, Sanjun Cai, Junjie Peng

    Journal: Clinical Colorectal Cancer, 2018, Vol., , DOI:10.1016/j.clcc.2018.10.005

  • Challenges That Hinder the Translation of Clinical Advances Into Practice: Results From an International Assessment in Colorectal Cancer.

    Author: Lazure P, Marshall JL, Hayes SM, Murray S.

    Journal: Clin Colorectal Cancer. 2016 Mar;15(1):54-66. doi: 10.1016/j.clcc.2015.07.006. Epub 2015 Jul 29.

  • Intermediate Neoadjuvant Radiotherapy Combined With Total Mesorectal Excision for Locally Advanced Rectal Cancer: Outcomes After a Median Follow-Up of 5 Years.

    Author: Wang L, Li YH, Cai Y, Zhan TC, Gu J.

    Journal: Clin Colorectal Cancer. 2016 Jun;15(2):152-7. doi: 10.1016/j.clcc.2015.10.001. Epub 2015 Oct 22.

  • Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin.

    Author: Cohen SA, Wu C, Yu M, Gourgioti G, Wirtz R, Raptou G, Gkakou C, Kotoula V, Pentheroudakis G, Papaxoinis G, Karavasilis V, Pectasides D, Kalogeras KT, Fountzilas G, Grady WM.

    Journal: Clin Colorectal Cancer. 2016 Jun;15(2):164-9. doi: 10.1016/j.clcc.2015.10.005. Epub 2015 Nov 11.

  • Autologous Cytokine-Induced Killer Cells Improves Overall Survival of Metastatic Colorectal Cancer Patients: Results From a Phase II Clinical Trial.

    Author: Zhao H, Wang Y, Yu J, Wei F, Cao S, Zhang X, Dong N, Li H, Ren X.

    Journal: Clin Colorectal Cancer. 2016 Feb 16. pii: S1533-0028(16)30017-2. doi: 10.1016/j.clcc.2016.02.005. [Epub ahead of print]

  • Outcome of Molecular Targeted Agents Plus Chemotherapy for Second-Line Therapy of Metastatic Colorectal Cancer: A Meta-Analysis of Randomized Trials.

    Author: Pei X, Liu Y, Sun L, Zhang J, Fang Y, Liao X, Liu J, Zhang C, Yin T.

    Journal: Clin Colorectal Cancer. 2016 Mar 31. pii: S1533-0028(16)30030-5. doi: 10.1016/j.clcc.2016.03.005. [Epub ahead of print]

  • Intermediate Neoadjuvant Radiotherapy Combined With Total Mesorectal Excision for Locally Advanced Rectal Cancer: Outcomes After a Median Follow-Up of 5

    Author: wanglinmd

    Journal: Clinical Colorectal Cancer, 2016.

  • Outcome of Molecular Targeted Agents Plus Chemotherapy for Second-Line Therapy of Metastatic Colorectal Cancer: A Meta-Analysis of Randomized Trials

    Author: Tiejun Yin

    Journal: Clinical Colorectal Cancer, 2016.